In another study conducted by Patel et al.,demonstrated that short-term colchicine therapy significantly attenuated the expression of IL-1β, IL-18, and IL-6 in patients with acute coronary syndromes, supporting its mechanistic role in suppressing vascular inflammation. Here, IL18 is linked to acute coronary syndrome.